Beckman Coulter’s Bruce Wallace is one of the few executives in the molecular biology tools industry whose job responsibilities and job title specifically address the emerging systems-biology market.

Wallace, 54, is vice president and director of Beckman’s systems biology business center, a post he has held for one year after joining the Fullerton, Calif., company three years ago from Nanogen, where he was vice president for research and development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Wired reports that 23andMe is trying to bolster its outside collaborations.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.